EE200400007A - Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid - Google Patents

Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE200400007A
EE200400007A EEP200400007A EEP200400007A EE200400007A EE 200400007 A EE200400007 A EE 200400007A EE P200400007 A EEP200400007 A EE P200400007A EE P200400007 A EEP200400007 A EE P200400007A EE 200400007 A EE200400007 A EE 200400007A
Authority
EE
Estonia
Prior art keywords
phenylethanolamine
preparation
pharmaceutical compositions
crystalline form
compositions containing
Prior art date
Application number
EEP200400007A
Other languages
English (en)
Inventor
Caron Antoine
Monnier Olivier
Obert Sabrina
Roche J�rome
Ziri Isabelle
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200400007A publication Critical patent/EE200400007A/et
Publication of EE05380B1 publication Critical patent/EE05380B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200400007A 2001-06-28 2002-06-27 FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid EE05380B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108562A FR2826651B1 (fr) 2001-06-28 2001-06-28 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
PCT/FR2002/002235 WO2003002510A1 (fr) 2001-06-28 2002-06-27 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (2)

Publication Number Publication Date
EE200400007A true EE200400007A (et) 2004-02-16
EE05380B1 EE05380B1 (et) 2011-02-15

Family

ID=8864888

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400007A EE05380B1 (et) 2001-06-28 2002-06-27 FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid

Country Status (30)

Country Link
US (1) US6992211B2 (et)
EP (1) EP1404641B1 (et)
JP (2) JP4171413B2 (et)
KR (1) KR100869017B1 (et)
CN (1) CN1269797C (et)
AR (1) AR034648A1 (et)
AT (1) ATE403642T1 (et)
AU (1) AU2002333942B2 (et)
BR (1) BR0210661A (et)
CA (1) CA2450213C (et)
CY (1) CY1110099T1 (et)
CZ (1) CZ301450B6 (et)
DE (1) DE60228088D1 (et)
DK (1) DK1404641T3 (et)
EE (1) EE05380B1 (et)
ES (1) ES2307798T3 (et)
FR (1) FR2826651B1 (et)
HK (1) HK1063621A1 (et)
HU (1) HUP0401229A3 (et)
IL (2) IL159134A0 (et)
MX (1) MXPA03011742A (et)
NO (1) NO331169B1 (et)
NZ (1) NZ530140A (et)
PL (1) PL206680B1 (et)
PT (1) PT1404641E (et)
SI (1) SI1404641T1 (et)
SK (1) SK287355B6 (et)
TW (1) TWI286129B (et)
WO (1) WO2003002510A1 (et)
ZA (1) ZA200309512B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
CN108603193B (zh) 2015-12-30 2022-07-22 生物辐射实验室股份有限公司 分裂循环和tape扩增

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
ATE116284T1 (de) * 1987-08-12 1995-01-15 Sanofi Sa Verfahren zur o-alkylierung von n- (hydroxy)aralkylphenylethanolamin.
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Also Published As

Publication number Publication date
EP1404641A1 (fr) 2004-04-07
NZ530140A (en) 2005-05-27
CZ301450B6 (cs) 2010-03-03
DE60228088D1 (de) 2008-09-18
SI1404641T1 (sl) 2008-10-31
BR0210661A (pt) 2004-10-05
IL159134A (en) 2009-07-20
JP2004530725A (ja) 2004-10-07
NO20035839L (no) 2004-03-01
CZ20033531A3 (en) 2004-04-14
MXPA03011742A (es) 2004-07-01
CY1110099T1 (el) 2015-01-14
SK15932003A3 (sk) 2004-05-04
CN1522241A (zh) 2004-08-18
FR2826651B1 (fr) 2005-09-02
JP4799592B2 (ja) 2011-10-26
CA2450213C (en) 2011-02-15
KR100869017B1 (ko) 2008-11-17
WO2003002510A1 (fr) 2003-01-09
ATE403642T1 (de) 2008-08-15
JP4171413B2 (ja) 2008-10-22
CA2450213A1 (en) 2003-01-09
CN1269797C (zh) 2006-08-16
AU2002333942B2 (en) 2008-02-28
PL206680B1 (pl) 2010-09-30
ZA200309512B (en) 2004-12-08
AR034648A1 (es) 2004-03-03
KR20040017817A (ko) 2004-02-27
PL368055A1 (en) 2005-03-21
SK287355B6 (sk) 2010-08-09
FR2826651A1 (fr) 2003-01-03
TWI286129B (en) 2007-09-01
DK1404641T3 (da) 2008-12-08
HUP0401229A3 (en) 2008-03-28
EE05380B1 (et) 2011-02-15
EP1404641B1 (fr) 2008-08-06
ES2307798T3 (es) 2008-12-01
US6992211B2 (en) 2006-01-31
US20040180953A1 (en) 2004-09-16
IL159134A0 (en) 2004-05-12
PT1404641E (pt) 2008-09-22
HUP0401229A2 (hu) 2004-10-28
HK1063621A1 (en) 2005-01-07
NO331169B1 (no) 2011-10-24
JP2009029804A (ja) 2009-02-12

Similar Documents

Publication Publication Date Title
EE05285B1 (et) Perindopriili tert-butlamiinsoola kristalliline β-vorm, protsess selle valmistamiseks ja seda sisaldavad farmatseutilised kompositsioonid
EE201100023A (et) Ravimite kombinatsioon, mis sisaldab rasvhapet ja uridiin hendit, ja selle kasutamine
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
HUP0400240A3 (en) Combinations of substituted oxazolidinones and other active ingredients and pharmaceutical compositions containing them
EE200300003A (et) Perindopriili tert-butüülamiinsoola kristallilinekamma-vorm, selle valmistamise protsess ning sedasisaldavad farmatseutilised kompositsioonid
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
PT1453517E (pt) Formulacoes farmaceuticas de derivados de platina
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
DK3219705T3 (da) Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
HUP0401665A3 (en) Alfa and beta-form crystal of an aminothiazolyl acetanilide derivative, their use and pharmaceutical compositions containing them
EE200200530A (et) Glükogeenfosforülaasi inhibiitorite farmatseutilised kompositsioonid
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
DE60210020D1 (de) Herstellung von Polysulfidzusammensetzungen
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
EP2157083A3 (en) Pharmaceutical compositions containing crystalline form (I) of lercanidipine hydrochloride
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
EE200400018A (et) Gatifloksatsiini ja rasvhappe kristalne kopretsipitaat, selle valmistamise meetod ja seda sisaldav ravimkoostis
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
EE200400007A (et) Fenüületanoolamiini kristallivorm, selle valmistamine ja seda sisaldavad farmatseutilised kompositsioonid
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
EE05406B1 (et) Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon
EE200200534A (et) Torasemiidi amorfne modifikatsioon, selle valmistamine ja kasutamine soolade saamiseks ning seda sisaldav farmatseutiline preparaat
AU2003272071A8 (en) Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
HUP0401798A3 (en) Use of rosuvastatin for preparation of pharmaceutical compositions usable in pre demented states

Legal Events

Date Code Title Description
HC1A Change of owner name
MM4A Lapsed by not paying the annual fees

Effective date: 20120627